An Act To Amend Title 18 And Title 29 Of The Delaware Code Relating To The Delaware Pre Authorization Act Of 2025.
Summary
SB12 is an act amending Title 18 and Title 29 of the Delaware Code to implement the Delaware Pre Authorization Act of 2025. Based on the bill caption, the measure appears to establish or revise a prior authorization framework affecting insurance regulation and related state administrative provisions. The bill text provided is unavailable, so the specific statutory changes are not visible here, but the title indicates changes in both the insurance code and general state government code.
The bill passed the Senate on third reading by a 19-0 vote on May 15, 2025, and passed the House on third reading by a 39-0 vote on June 25, 2025. Those unanimous votes suggest broad bipartisan support and little visible opposition in the recorded floor votes. No committee transcript was provided, so there is no additional public discussion to indicate amendments, implementation concerns, or stakeholder objections.
Impact
SB12 likely affects Delaware insurance law by creating or modifying requirements for prior authorization, a utilization-management process used by health insurers to approve certain medical services, procedures, or prescriptions before coverage is provided. By amending Title 18, the bill would alter insurance regulation; by amending Title 29, it may also direct state agencies, enforcement, reporting, or implementation duties. The practical impact would fall on insurers, health plans, providers, and patients subject to prior authorization rules in Delaware.
Sentiment
The recorded sentiment around SB12 appears strongly favorable. Both chambers approved the bill unanimously, indicating broad legislative agreement and no recorded floor-level dissent. Because no committee discussion transcript is available, the available record does not show organized opposition or significant controversy in the legislative process.
Contention
No specific points of contention are visible in the materials provided. The only identifiable area where disagreement could arise, based on the subject matter, would be between supporters of prior authorization reform and stakeholders concerned about insurer administrative burden, utilization controls, or cost impacts. However, the unanimous votes suggest any such concerns were either resolved before final passage or were not significant enough to affect the bill's advancement.